Utah's Experiment With AI-Driven Prescription Renewals
In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”
The structural problems that inspired this experiment are real. Many patients face physical or cost barriers to visiting a physician to renew prescriptions—a problem set to intensify with mounting rural clinician shortages and rollbacks of Medicaid coverage and Affordable Care Act premium subsidies. Only licensed prescribers can renew prescriptions (as opposed to dispensing refills) and pharmacists generally do not qualify. When patients request renewals by email, they are asking prescribers to perform unreimbursed work that adds to an already crushing administrative load. Many prescriptions for treating chronic conditions change little over time. Given these realities, the Utah pilot program deserves thoughtful analysis—not dismissal out of hand.